OPERATIONS TO BEGIN: Specialty Pharmacy in August • Compounding Pharmacy in October • cGMP Manufacturing 2028

Where Pharmaceutical Precision Meets Provider and Patient Needs

Licensed. Compliant. Provider-Directed.

Licensed 503A Compounding Pharmacy and Specialty Pharmacy

OPERATIONS TO BEGIN: Specialty Pharmacy in August • Compounding Pharmacy in October • cGMP Manufacturing 2028

Specialized Compounding

Working directly with prescribers to formulate medications tailored to each individual — the right strength, the right dosage form, the right fit.

Peptide Therapeutics

Quality-controlled, provider-prescribed compounding with validated FDA supply chain processes and formulary depth.

Hormone Replacement Therapies

Compounded and dispensed according  to individually prescribed protocols where commercial one-size-fits-all options fall short.

Therapeutics for Solid Organ Transplant

Providing premium patient care and support from delivery to coordination of nursing and labs — backed by decades of clinical experience.

Who We Are

1Elevan Biopharmaceuticals is a vertically integrated, U.S.-based therapeutics company focused on safety, quality, and responsible innovation. We combine licensed compounding pharmacy and specialty pharmacy operations to support provider-directed care with future cGMP manufacturing to strengthen domestic peptide infrastructure.

Chronic Disease Focus

Provider-directed support for high-burden chronic health conditions — expanding treatment access responsibly and sustainably.

Safety & Compliance

State and federal licensure, independent lab testing,  and structured quality validation throughout.

Responsible Innovation

Infrastructure-first approach with AI-supported optimization — focusing on measured, disciplined growth over speed.